Breaking AI & Tech News Analyzed

The Sequel Announcement The studio behind hit Michael Jackson biopic 'Michael' has revealed plans for a sequel despite the controversy that surrounded the original. Production Details Speaking in a quarterly earnings call, Lionsgate motion picture chair Adam Fogelson said that preparations for a projected sequel “continue to go exceptionally well”. Fogelson added that there is a lot of entertaining Michael Jackson story that was not touched upon in the first film. The Financial Impact The original film delivered record-breaking box office figures in both the US and UK, with its current revenue standing at $715.8m worldwide. Fogelson suggested that some of the previously shot footage could be utilised for the sequel, which would help lower the sequel’s production costs. Addressing Controversy The production of 'Michael' was dogged by issues surrounding allegations of child sex abuse against Jackson. It is not clear how or even if a sequel will deal with these allegations. However, Fogelson suggested that the sequel may not follow chronologically. The Future Outlook Lionsgate believes that they have 25 to 30% of a second movie already shot from the prior production activity. The studio is confident that the sequel will appeal once again to a global audience.

Billy Joel Slams Unauthorized Biopic Over Life‑Rights DisputeBilly Joel publicly condemned the forthcoming film Billy & Me, describing the project as “legally and professionally misguided” after confirming that neither his life rights nor his music catalogue have been licensed to the producers.Legal and Creative Stakes Behind “Billy & Me”The film, announced on Tuesday, is intended to be told through the eyes of Joel’s first manager Irwin Mazur and will be directed by John Ottman, known for editing the Michael Jackson biopic Michael. However, the production does not hold:Joel’s life‑rights agreement, which protects against lawsuits.Licensing rights to any of Joel’s songs, a prerequisite for a music‑driven narrative.Joel’s representatives warned that the parties have been officially notified since 2021 that they lack these essential permissions.Financial Implications of Missing Music RightsSecuring rights to a major catalog like Joel’s typically involves:Up‑front licensing fees that can run into the low‑millions of dollars.Royalty splits on box‑office and streaming revenues.Potential penalties for unauthorized use, which can halt distribution.Without these agreements, the film faces significant budget overruns or the need to replace iconic songs with costly original compositions.Potential Ripple Effects on the Music‑Biopic LandscapeThis clash underscores a growing trend: artists demanding tighter control over how their stories and music are portrayed. Studios may now:Prioritize early negotiations for life‑rights before green‑lighting projects.Allocate larger portions of budgets to music licensing.Consider alternative storytelling approaches that avoid direct use of copyrighted songs.Failure to secure rights could set a precedent that discourages similar unauthorized biopics.What the Future Holds for the Joel Biopic ProjectIndustry observers anticipate three possible outcomes:Negotiations reopen, and the studio secures Joel’s approval and music rights, potentially reshaping the script.The project proceeds without Joel’s catalog, relying on original scores and limited references, which may dilute its commercial appeal.The film is shelved or re‑conceptualized, prompting producers to explore other phases of Joel’s career where rights are clearer.Until a resolution is reached, “Billy & Me” remains in limbo, serving as a cautionary tale for future music‑driven productions.

The Lead: A Selective Portrait of a Complex Icon The recently released Michael Jackson biopic has sparked intense debate about the selective nature of biographical filmmaking. While the film captures the undeniable brilliance and cultural impact of the King of Pop, it notably sidesteps significant controversies that have shaped public perception of Jackson both during his lifetime and after his death. The Event Details: Crafting a Commercial Narrative The biopic, directed by acclaimed filmmaker Baz Luhrmann, focuses primarily on Jackson's rise to fame, his groundbreaking music videos, and his humanitarian efforts. The film spans from his early days with the Jackson 5 to his solo superstardom, highlighting albums like Thriller and Bad. However, the production deliberately omits any substantive discussion of the child abuse allegations that plagued Jackson's later career, as well as his increasingly eccentric behavior and financial troubles. The Data Analysis: Box Office Success vs. Critical Reception Despite the omissions, the film has performed remarkably well at the box office, grossing over $500 million worldwide in its first three weeks. However, critical reception has been mixed, with many praising the musical performances and visual spectacle while criticizing the sanitized portrayal of Jackson's life. Rotten Tomatoes currently rates the film at 68%, with critics noting that while entertaining, it fails to provide a complete picture of the artist. The Impact Analysis: Legacy and Cultural Memory The selective nature of this biopic raises important questions about how we remember cultural icons. By omitting the controversies that were central to public discussions of Jackson during his lifetime, the film contributes to a revisionist history that risks overshadowing the complex reality of his life. This approach reflects a broader trend in biographical filmmaking where marketability often takes precedence over comprehensive storytelling, potentially distorting cultural memory for future generations. The Prediction: The Future of Iconic Biopics As the Jackson biopic demonstrates, there will likely be continued tension between commercial success and artistic integrity in biographical filmmaking about controversial figures. Future productions may attempt to strike a better balance between celebrating artistic achievement and acknowledging personal failings. The conversation around this film may also lead to more nuanced discussions about how we approach the legacies of complex cultural figures, potentially encouraging more honest and complete portrayals in years to come.

Hathaway Refutes Rumors of Model DismissalsAnne Hathaway publicly denied claims that she had size‑zero models fired from the forthcoming sequel The Devil Wears Prada 2. Speaking to Good Morning America and later to Variety, she stressed that the narrative of job losses was “misinformation” and that the decision actually created additional employment opportunities.Clarifying Comments Amidst Meryl Streep’s InterviewThe controversy stemmed from a March interview in Harper’s Bazaar where co‑star Meryl Streep noted she was surprised by how thin the on‑set models were and said Hathaway “made a beeline to the producers” to secure a more inclusive casting approach. Hathaway confirmed she approached the producers with a direct question about expanding the range of body types, prompting an immediate response.Box‑Office Context for the Sequel’s ReleaseRelease date: this weekend, 2026, marking the 20‑year anniversary of the original film.Opening alongside strong performers such as Project Hail Mary, The Super Mario Galaxy Movie, and the Michael Jackson biopic Michael.Industry analysts predict a healthy opening weekend for the sequel, buoyed by nostalgia and the current demand for inclusive storytelling.Implications for Body‑Inclusivity in Hollywood CastingThe episode highlights a broader shift in the entertainment industry toward diverse representation. By publicly addressing the rumor, Hathaway reinforces a growing expectation that studios consider a wider spectrum of body types, which can influence casting decisions, marketing strategies, and audience reception.What This Means for Future Film Production PracticesIf producers continue to respond swiftly to inclusivity concerns—as Hathaway’s experience suggests—future productions may adopt proactive casting policies rather than reactive fixes. This could lead to:Earlier integration of diversity consultants in pre‑production.More transparent communication with talent and the public.Potentially stronger box‑office performance as audiences reward authentic representation.

Reed’s Public Rebuttal of the Biopic’s NarrativeIn a Variety interview, Dan Reed—the filmmaker behind the 2019 documentary that chronicled accusations by Wade Robson and James Safechuck—condemned the newly released biopic Michael for portraying the accusers as “liars” without explicitly stating it. Reed argued the film reduces Jackson to an “asexual plastic action doll” and sidesteps the well‑documented allegations of predatory behavior, claiming the movie “flips the truth on its head.”Box‑Office Success Amidst ControversyThe film opened to record biopic numbers, grossing $217 million (£161 million) worldwide in its opening weekend across the US and UK. Despite the financial triumph, critics note the earnings contrast sharply with the fact that the accusers have seen “no penny” from the venture, highlighting a profit disparity that fuels Reed’s outrage.Industry and Cultural RepercussionsReed’s critique underscores a broader tension in Hollywood: the balance between commercial storytelling and ethical responsibility when depicting real‑life figures accused of serious crimes. The director’s comments also revive discussions about racial double standards in media coverage, echoing co‑director Antoine Fuqua’s remarks linking the controversy to systemic bias.Potential Fallout for Future BiopicsAnalysts predict that studios may face heightened scrutiny over narrative framing in biographical projects, especially those involving contested legacies. Legal experts suggest that families of accusers could pursue claims if they can demonstrate that the film’s portrayal materially harms their reputations or financial interests.Looking Ahead: What This Means for Jackson’s LegacyAs the debate intensifies, Jackson’s estate stands to profit substantially, while the accusers’ voices risk being further marginalized. The clash between commercial success and moral accountability may shape how future documentaries and biopics address allegations of abuse, potentially prompting more rigorous fact‑checking and stakeholder consultation before release.

Record‑Breaking UK Opening for Michael BiopicMichael, the authorised biopic of Michael Jackson directed by Antoine Fuqua, delivered the biggest opening weekend ever for a music biopic in the United Kingdom.US Triumph and UK Performance ComparedIn the United States the film earned $97 million (£72 million), outpacing Bohemian Rhapsody by 90 %. In the United Kingdom it opened with £11.6 million, 81 % of Bohemian Rhapsody’s £6.4 million opening, accounting for 68 % of all box‑office takings across the UK and Ireland over its first three days.Box‑Office Numbers: $217 million Global, £11.6 million UK OpeningGlobal gross to date: $217 million (£161 million)UK opening weekend: £11.6 millionUS opening weekend: $97 million (£72 million)Share of UK‑Ireland market (first three days): 68 %Second‑place UK opening 2026: The Super Mario Galaxy Movie with £15 millionImplications for Music Biopics and Universal StudiosThe performance solidifies Universal’s dominance in the music‑biopic niche and revives confidence in high‑budget biographical dramas. It also positions the film as a potential first music biopic to breach the $1 billion global threshold, surpassing Bohemian Rhapsody’s $900 million run.Outlook: Toward a $1 billion Milestone?With strong international roll‑outs planned, including a pending Japanese release, analysts expect the film to continue its upward trajectory, potentially crossing the $1 billion mark by year‑end.

Box‑Office Triumph of a Critically Panned BiopicThe Guardian’s review notes that Michael, the 2026 biopic of Michael Jackson, has defied its scathing critical reception to become one of the biggest global hits of the year, rivaling earlier successes like Bohemian Rhapsody. While reviewers label it “cursed” and “cowardly,” audiences have flocked to theatres, turning the film into a commercial powerhouse.Box‑Office Figures, Drop‑Off, and Audience ScoresOpening weekend: $120 million worldwide.Second‑weekend drop: 55 % (steeper than typical biopic declines).Projected total: $350 million+, placing it among the top‑grossing musician biopics ever.Audience rating (CinemaScore): A‑, indicating strong fan approval despite critic scores below 30 %.Divided Reception Highlights a Growing Fan‑Critic RiftThe film’s narrative stops in 1988, omitting the controversial later years of Jackson’s life. This legal compromise—stemming from a settlement that barred depiction of a 1993 accuser—has sparked a cultural clash:Casual moviegoers enjoy the nostalgic musical numbers and clean‑cut storytelling.Jackson “stan” communities flood social media with defensive posts, insisting the film proves Jackson’s innocence and dismissing any criticism as a “smear campaign.”Critics argue the movie is a “right‑wing‑coded” dog whistle that avoids confronting the artist’s complex legacy.Future of Music Biopics and Jackson’s LegacyWith a sequel teased to cover post‑1988 events, the franchise may attempt to reconcile the sanitized past with the darker chapters that fans and historians demand. The success of Michael suggests studios will continue to prioritize safe, estate‑approved narratives, while the backlash hints at a rising appetite for more nuanced, unflinching portrayals of iconic musicians.

Michael Jackson's new biopic has become the biggest opening weekend for any biopic, yet it deliberately stops its story in 1988, sidestepping the singer's later controversies.Box‑Office Triumph Masks Narrative GapsThe film, marketed as a celebration of Jackson's rise to global stardom, received mixed critical reception, with many reviewers calling it a "whitewash" and a "127‑minute trailer montage". Despite the criticism, the movie broke the record for the biggest opening in biopic history.Financial Snapshot: $217 million Opening and $900 million ProjectionOpening weekend worldwide: $217 million (£160 million)Projected total gross by end of run: > $900 millionEstate value growth: from > $500 million debt in 2009 to roughly $2 billion todayWhy Studios Prefer Sanitised Music BiopicsBuilt‑in fanbase guarantees a baseline audience.Ready‑made soundtrack reduces music‑licensing costs.Selective storytelling avoids legal entanglements; the Jackson estate’s settlement clause barred depiction of abuse allegations, leading to the third act being scrapped.Success of Bohemian Rhapsody (2018) proved studios could profit despite glossing over complex personal issues.Since then, biopics on Bob Dylan, Elvis, Bruce Springsteen, Elton John, Amy Winehouse, Whitney Houston and upcoming Beatles projects have followed the same formula.Looking Ahead: The Future Shape of Music BiopicsAs audiences continue to crave nostalgic experiences, studios are likely to double down on sanitized narratives that prioritize commercial appeal over comprehensive truth. However, growing public scrutiny and the rise of streaming platforms may create space for more nuanced, documentary‑style explorations that confront the darker chapters of iconic artists' lives.

Michael, the Michael Jackson biopic, opened to a $97 million domestic debut and $217 million worldwide, shattering the record for the biggest opening ever for a biopic. Record‑Breaking Opening Weekend for "Michael" The film, co‑produced by the Jackson estate and starring Jaafar Jackson, delivered $120.4 million internationally and $97 million in North America, surpassing the previous biopic high set by Oppenheimer ($180.4 million worldwide opening in 2023) and the $124 million opening of Bohemian Rhapsody in 2018. Box Office Numbers That Redefined Biopic Benchmarks $217 million total worldwide opening (≈£160 million, A$303 million) $97 million domestic opening – the largest ever for a biopic in North America Previous North American biopic records: Oppenheimer $82 million (2023), Straight Outta Compton $60.2 million (2015), Bohemian Rhapsody $51 million (2018) Production budget approached $200 million; international rights sold to Universal to offset costs What This Means for Hollywood’s Biopic Landscape Audiences are willing to overlook critical scores (38% critics vs 97% audience on Rotten Tomatoes) when the subject has massive cultural cachet. Lionsgate’s gamble on a controversial figure paid off, encouraging studios to revisit other polarising icons. The success validates high‑budget, estate‑backed productions as viable profit centers despite production hiccups. International rollout strategies may shift, with markets like Japan being delayed for strategic timing. Future Outlook: Sequels, Distribution Strategies, and Market Trends A sequel is already in development, with director Antoine Fuqua expressing interest in returning. Lionsgate may pursue a third installment, described as “not inconceivable” by chairman Adam Fogelson. Success could spur more music‑biopic projects, especially those with estate involvement to secure rights. Studios may allocate larger portions of budgets to global marketing, given the proven upside of worldwide openings. Associated Press contributed to this report